Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

The Latest Breaking News from EBS

Big Rallies Brewing? 3 Analyst Favorites to Watch Closely

Despite share price pops after earnings, SKYT, EBS, and BLZE may still have room to rally further, as each firm has garnered strong analyst support.

‘Deeply wrong’: would you use a barbecue to cook a full English breakfast?

‘Deeply wrong’: would you use a barbecue to cook a full English breakfast?

If so, you’ve got company – nearly one in six Britons have prepared bacon and eggs on an open flame. But not everyone is happy about the practice

The Guardian - UK

Electoral bond scheme ‘muddied waters’ of corporate political donations, says Congress

Electoral bond scheme ‘muddied waters’ of corporate political donations, says Congress

The Congress alleged that every day a new dimension is emerging in the electoral bond scheme (EBS) and alleged that the EBS deliberately “muddied” the waters of corporate political donations

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

India’s voters deserve a bond — of probity

A reasonable way forward in political party funding can only be found through a well-meaning parliamentary consultative process and not through court fiats, or laws and policies crafted in secret

AIB to increase rates on fixed mortgages as homeowners could fork out extra €300

The bank confirmed the price increases won’t affect current customers, only new customers and those switching

White House Outlines New Monkeypox Vaccine Strategy: What You Need To Know

The White House unveiled the first phase of its national monkeypox vaccine strategy, with plans to send doses to areas with confirmed outbreaks. The U.S. Department of Health and Human Services plans to distribute 296,000 doses of the Bavarian Nordic A/S's (OTC:BVNRY) Jynneos vaccine, an already-developed monkeypox vaccine. The U.S. is releasing 56,000 doses of…

Emergent Bio Says Johnson & Johnson Breached COVID-19 Vaccine Contract

Emergent BioSolutions Inc (NYSE: EBS) said Johnson & Johnson (NYSE: JNJ) had breached an agreement by failing to buy the company's minimum quantity of COVID-19 vaccines.

inkl

Read news from The Economist, FT, and more,
with one subscription

SNGX: Phase 2a Trial of SGX302 in Psoriasis to Initiate in Second Half of 2022…

By David Bautz, PhD NASDAQ:SNGX READ THE FULL SNGX RESEARCH REPORT

Almost 400M COVID-19 Vaccine Doses Lost Due To Emergent's Baltimore Plant Fiasco

Almost 400M COVID-19 Vaccine Doses Lost Due To Emergent's Baltimore Plant Fiasco

According to a recent report from the US House select subcommittee on the coronavirus crisis, Emergent Biosolutions Inc (NYSE:EBS) might have destroyed nearly 400 million doses of COVID-19 vaccines after failing to meet quality standards. Initially, 75 million - 85 million doses of drug substance were said to be destroyed after contamination. "Despite major…

Emergent BioSolutions Suspends CDMO Guidance As It Awaits Clarity On COVID-19 Vaccine Requirements

Emergent BioSolutions Suspends CDMO Guidance As It Awaits Clarity On COVID-19 Vaccine Requirements

Emergent BioSolutions Inc (NYSE:EBS) reported Q1 sales of $307.5 million, down 10% Y/Y, beating the consensus of $283 million. Total product sales increased 72% to $237.1 million, while Contract development & manufacturing (CDMO) revenues declined 67% to $60.8 million. The decrease is primarily due to the company's decision to initiate maintenance and…

Russian Rouble Drops to Fresh Record Low in Thin Offshore Trade

Russian Rouble Drops to Fresh Record Low in Thin Offshore Trade

Russia's rouble tumbled to a fresh record low in thin offshore trade with local markets closed for trading until at least Wednesday. The rouble weakened to 130.9338 to the dollar after closing at 121.037 on Friday, according to Refinitiv data. On the EBS trading platform, the rouble softened to as…

Asharq Al-Awsat

AOL Plus Time Warner Equals...What?

Do the math, and you might wonder if this company’s long-term annual return to investors can beat a Treasury bond’s.

1

People

180,339 stories

Carolyn Maloney

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

Organisations

the Supreme Court

AstraZeneca Plc

inkl

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

360,645 stories

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.

Download on the AppStore

Get it on Google Play